ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.235
      -0.05%
      Bitcoin
      67,759.97
      -0.58%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Legend Biotech Corporation (LEGN)

      7. Legend Biotech Corporation (LEGN) Financials

      Legend Biotech Corporation

      Legend Biotech Corporation (LEGN)

      NASDAQ
      58.74
      0.50
      (0.86%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      58.50
      -0.24
      (-0.41%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Legend Biotech Corporation Financial Summary

      The current LEGN market cap is 10.69B. The company's latest EPS is USD and P/E is N/A.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 44.54M73.33M96.01M137.59M93.99M
      Operating Income -116.13M-104.32M-92.75M-62.93M-117.86M
      Net Income -112.1M-199.13M-62.21M-144.82M-59.79M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 57.26M75.68M89.79M117.01M285.14M
      Operating Income -137.05M-229.2M-373.04M-458.05M-442.22M
      Net Income -132.97M-303.48M-386.21M-446.35M-518.25M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.21B1.93B1.84B1.85B1.78B
      Total Liabilities 556.2M523.63M499.7M597.24M611.05M
      Total Equity 653.16M1.41B1.34B1.25B1.16B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 287.72M721.01M1.12B1.33B1.85B
      Total Liabilities 410.58M440.75M647.16M586.65M597.24M
      Total Equity -122.87M280.26M471.21M744.31M1.25B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -141.05M-236.78M-297.63M-393.28M15.52M
      Investing 17.93M-105.65M-314.72M92.79M-396.15M
      Financing -286k789.6M790.57M791.49M831k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -83.07M-223.01M-198.47M-201.28M-393.28M
      Investing -58.65M-24.17M-194.98M-77.09M92.79M
      Financing 14.67M618.88M626.66M377.98M791.49M

      Stats and Ratios

      Market Cap 10.69B
      Price to Earnings Ratio N/A
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 0
      Dividend Yield -

      Share Statistics

      Shares Outstanding 181.91M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 4.4 (7.34%)

      Company Info

      Company Name Legend Biotech Corporation
      Address 4th floor, harbour place
      grand cayman KY1 1002
      Website https://www.legendbiotech.com
      Industry pharmaceutical preparations (2834)